Inequitable conduct may be found where a patentee knowingly failed to disclose to a USPTO examiner contradictory representations made in another forum with respect to prior art. In Therasense, Inc. v. Becton, Dickinson & Co., Nos. 08-1511, -1512, -1513, 1514, -1595 (Fed. Cir. Jan. 25, 2010), the Federal Circuit found U.S. Patent No. 5,820,551 (“the ’551 patent”), owned by Abbott Diabetes Care, Inc. (Abbott), Therasense, Inc.’s (Therasense) successor, to be unenforceable due to inequitable conduct during prosecution. The ’551 patent related to disposable glucose test strips utilizing electrochemical sensors, and its claims were particularly directed to electrochemical sensors lacking a protective membrane.
Please see full article below for more information.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.
Intellectual Property Updates, Administrative Law Updates
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Finnegan | Attorney Advertising